Amid COVID-19 precautions, medical centers continue to treat patients with other serious conditions. By Kelly ServickScience's COVID-19 reporting is supported by the Pulitzer Center.Myron Cohen has run clinical trials through hurricanes and civil unrest.
Now, the infectious disease researcher at the University of North Carolina, Chapel Hill, says he and his colleagues are in a new situation: trying to carry out large, international trials in the midst of coronavirus lockdowns.
Cohen co-leads a network of HIV prevention trials, some of which have paused during the pandemic. But for other studies, he says, “stopping would be of grave consequence” to participants.